Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've missed a tirzepatide dose, the answer is simpler than most people fear: take it as soon as you remember, provided at least four days remain before your next scheduled injection. If fewer than four days remain, skip it and carry on with your usual day. Tirzepatide (Mounjaro) is a prescription-only medicine, and any uncertainty about your dosing schedule is best resolved with the prescriber who knows your full clinical picture — but the rule above reflects what the SmPC advises, and it's worth understanding why.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is some version of this: "I missed my injection on Monday, have I ruined everything?" The short answer is no. Tirzepatide has a long half-life; the medicine you injected the week before is still doing meaningful work even several days later. One missed dose does not reset your body's response or undo recent weight changes.
Where people go wrong is in trying to compensate. Taking a catch-up dose on top of a regular one is the main source of preventable side effects in this medicine. The nausea that many people experience in the early weeks of treatment is dose-related, so doubling up is essentially volunteering for the worst of it. The Patient Information Leaflet for tirzepatide dosing is explicit: if you realise you've missed an injection more than four days after it was due, skip it entirely.
The four-day window is the hinge the whole rule turns on. Within four days of the missed dose, take it and then return to your usual schedule. Beyond four days, leave it and wait. Our Mounjaro missed dose guide covers exactly what to do in both scenarios, so it's worth a read before you make any changes to your injection timing.
Missing one or even two injections is a different situation from going without tirzepatide for several weeks. A longer gap matters for two reasons. First, appetite and blood-sugar regulation may have shifted back toward baseline, which means the dose that felt manageable before could feel more intense when restarted. Second, if you had titrated up to a higher strength, resuming at that level after a sustained break carries a higher risk of side effects than it did when you first reached it.
This is covered in more detail for people who've missed a full week of Mounjaro or longer. The practical implication is that your prescriber may want to consider whether you should step back to a lower dose before continuing, rather than picking up where you left off. That decision belongs with the clinician, not a general guide.
The one-week gap scenario is common enough that it's worth reading about specifically if that's where you are. The NHS medicines page for tirzepatide also covers missed doses in plain language and is a reliable reference to bookmark.
Life doesn't always cooperate with a fixed weekly injection day. The good news is that tirzepatide allows some flexibility. You can move your injection day by up to three days in either direction (earlier or later) as long as at least four days separate any two consecutive doses. So if your usual day is Monday and you need to travel Thursday through Sunday, shifting to Thursday for one week is fine, provided your previous injection was at least four days earlier.
This flexibility is genuinely useful but has a limit. It's a short-term adjustment, not a reason to treat the schedule loosely. Consistency matters for how steadily the medicine works and for managing side effects. Once you've navigated the disruption, returning to a fixed day each week is the most straightforward approach.
For those deciding between available strengths and how titration fits into their schedule, the Mounjaro 5mg guide explains what a typical dose progression looks like in practice. Understanding the schedule before a disruption makes it easier to manage when one happens.
Most single missed doses are handled cleanly by the four-day rule, with no clinical involvement needed. But some situations do warrant a conversation. If you've missed multiple injections because of illness, surgery or a significant change in how you're tolerating the medicine, your prescriber needs to know before you continue, especially if you were on a higher dose and experienced significant gastrointestinal symptoms before the gap.
Similarly, if you've been managing side effects by informally reducing your dose (for example, skipping a week yourself when nausea was bad), that pattern is worth discussing openly. The FAQs on the nume, sorry, on the FAQ page cover common practical questions, and the clinical team is reachable seven days a week for aftercare queries. You can also report any unexpected or persistent side effects, including those that arise after a dose change, via the MHRA's Yellow Card scheme, it exists precisely so that real-world experiences with medicines like tirzepatide continue to be monitored.
If you're not yet on tirzepatide and are thinking through how the schedule would work for you, a free consultation through our treatment page is where to start. A prescriber will review your full picture the same day (a real clinician, not software) and can talk through what the weekly routine actually looks like.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.